Literature DB >> 21371376

Is it time to move to nucleic acid amplification tests screening for pharyngeal and rectal gonorrhoea in men who have sex with men to improve gonorrhoea control?

Christopher K Fairley, Marcus Y Chen, Catriona S Bradshaw, Sepehr N Tabrizi.   

Abstract

The use of nucleic acid amplification tests (NAAT), as well as or in preference to culture for non-genital sites is now recommended both in Australia and overseas because of their greater sensitivity and improved specificity. A survey of 22 Australian sexual health clinics who each year test over 14500 men who have sex with men (MSM) show that culture remains the predominate method for detecting gonorrhoea at pharyngeal (64%) and rectal (73%) sites. This editorial discusses the potential disadvantages of using culture over NAAT in relation to optimal gonorrhoea control among MSM and advocates that significantly improved control would be achieved by moving to NAAT with the proviso that culture samples are taken wherever possible on NAAT-positive samples and from clients with urethritis to ensure continued surveillance for antimicrobial resistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371376     DOI: 10.1071/SH10134

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  9 in total

1.  Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species.

Authors:  Sepehr N Tabrizi; Magnus Unemo; Athena E Limnios; Tiffany R Hogan; Stig-Ove Hjelmevoll; Susanne M Garland; John Tapsall
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

2.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urogenital and oral specimens using the cobas® 4800, APTIMA Combo 2® TMA, and ProbeTec™ ET SDA assays.

Authors:  Y Kumamoto; T Matsumoto; M Fujisawa; S Arakawa
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-04-11

3.  Neisseria gonorrhoeae false-positive result obtained from a pharyngeal swab by using the Roche cobas 4800 CT/NG assay in New Zealand in 2012.

Authors:  Arlo Upton; Collette Bromhead; David M Whiley
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

4.  Comparison of the cobas 4800 CT/NG test with culture for detecting Neisseria gonorrhoeae in genital and nongenital specimens in a low-prevalence population in New Zealand.

Authors:  Collette Bromhead; Amanda Miller; Mark Jones; David Whiley
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

5.  Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.

Authors:  Lilith K Whittles; Peter J White; Xavier Didelot
Journal:  PLoS Med       Date:  2017-10-31       Impact factor: 11.069

6.  A dynamic power-law sexual network model of gonorrhoea outbreaks.

Authors:  Lilith K Whittles; Peter J White; Xavier Didelot
Journal:  PLoS Comput Biol       Date:  2019-03-08       Impact factor: 4.475

7.  Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia.

Authors:  Qibin Duan; Chris Carmody; Basil Donovan; Rebecca J Guy; Ben B Hui; John M Kaldor; Monica M Lahra; Matthew G Law; David A Lewis; Michael Maley; Skye McGregor; Anna McNulty; Christine Selvey; David J Templeton; David M Whiley; David G Regan; James G Wood
Journal:  PLoS Comput Biol       Date:  2021-11-04       Impact factor: 4.475

8.  Treponema pallidum Macrolide Resistance and Molecular Epidemiology in Southern Africa, 2008 to 2018.

Authors:  Johanna M E Venter; Etienne E Müller; Mahlape P Mahlangu; Ranmini S Kularatne
Journal:  J Clin Microbiol       Date:  2021-08-04       Impact factor: 5.948

9.  Current levels of gonorrhoea screening in MSM in Belgium may have little effect on prevalence: a modelling study.

Authors:  J Buyze; W Vanden Berghe; N Hens; C Kenyon
Journal:  Epidemiol Infect       Date:  2018-02-01       Impact factor: 4.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.